Baltimore Washington Financial Advisors Inc. Buys 4,407 Shares of Stryker Corporation $SYK

Baltimore Washington Financial Advisors Inc. boosted its position in Stryker Corporation (NYSE:SYK) by 5.9% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 78,668 shares of the medical technology company’s stock after buying an additional 4,407 shares during the quarter. Stryker makes up about 1.2% of Baltimore Washington Financial Advisors Inc.’s holdings, making the stock its 28th largest position. Baltimore Washington Financial Advisors Inc.’s holdings in Stryker were worth $29,081,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Brighton Jones LLC grew its position in shares of Stryker by 15.4% in the fourth quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock valued at $1,643,000 after purchasing an additional 609 shares in the last quarter. Schnieders Capital Management LLC. purchased a new position in Stryker in the 2nd quarter worth approximately $205,000. First Horizon Advisors Inc. lifted its holdings in shares of Stryker by 17.7% during the 2nd quarter. First Horizon Advisors Inc. now owns 2,894 shares of the medical technology company’s stock worth $1,146,000 after acquiring an additional 435 shares during the last quarter. Souders Financial Advisors bought a new stake in Stryker during the second quarter worth about $212,000. Finally, Soltis Investment Advisors LLC boosted its stake in Stryker by 26.1% in the second quarter. Soltis Investment Advisors LLC now owns 1,796 shares of the medical technology company’s stock worth $710,000 after buying an additional 372 shares in the last quarter. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Insiders Place Their Bets

In other Stryker news, Director Ronda E. Stryker sold 250,000 shares of Stryker stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total value of $90,730,000.00. Following the sale, the director owned 2,457,331 shares of the company’s stock, valued at $891,814,566.52. The trade was a 9.23% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 5.90% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have issued reports on SYK. Weiss Ratings restated a “hold (c+)” rating on shares of Stryker in a research report on Monday, December 22nd. BTIG Research boosted their price objective on shares of Stryker from $410.00 to $412.00 and gave the company a “buy” rating in a research report on Friday, January 30th. Wall Street Zen raised Stryker from a “hold” rating to a “buy” rating in a research note on Saturday, February 21st. Sanford C. Bernstein increased their price target on shares of Stryker from $450.00 to $465.00 and gave the stock an “outperform” rating in a research note on Friday, January 9th. Finally, Royal Bank Of Canada reiterated an “outperform” rating and set a $435.00 target price on shares of Stryker in a research note on Friday, November 14th. Fourteen equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, Stryker presently has an average rating of “Moderate Buy” and an average price target of $428.61.

Stryker Stock Down 1.7%

SYK stock opened at $364.11 on Friday. The stock has a market cap of $139.34 billion, a P/E ratio of 43.35, a PEG ratio of 2.16 and a beta of 0.85. Stryker Corporation has a twelve month low of $329.16 and a twelve month high of $404.87. The business’s 50-day moving average price is $365.45 and its 200-day moving average price is $369.14. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, January 29th. The medical technology company reported $4.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.40 by $0.07. The company had revenue of $7.17 billion for the quarter, compared to the consensus estimate of $7.12 billion. Stryker had a net margin of 12.92% and a return on equity of 24.41%. Stryker’s revenue for the quarter was up 11.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $4.01 EPS. On average, equities research analysts forecast that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be issued a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a yield of 1.0%. The ex-dividend date is Tuesday, March 31st. Stryker’s dividend payout ratio (DPR) is currently 41.90%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.